National Pension Service Has $64.38 Million Holdings in Kenvue Inc. $KVUE

Key Points

• National Pension Service increased its Kenvue stake by 10.2% in the second quarter, owning 3.37 million shares valued at approximately $64.4 million. Institutional investors collectively hold 97.64% of the company.
• Analysts maintain a generally cautious outlook, with a consensus “Hold” rating and an average price target of $19.27. Kenvue’s latest quarterly results narrowly missed earnings and revenue estimates, though revenue rose 3% year over year.
• Kenvue declared a quarterly dividend of $0.21 per share, equivalent to an annualized $0.84 payout and a 4.7% yield.

National Pension Service boosted its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 10.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,369,149 shares of the company's stock after purchasing an additional 310,824 shares during the quarter. National Pension Service owned about 0.18% of Kenvue worth $64,384,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of KVUE. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Kenvue in the 2nd quarter worth about $6,528,000. Jump Financial LLC grew its stake in Kenvue by 210.6% in the 2nd quarter. Jump Financial LLC now owns 54,823 shares of the company's stock valued at $1,147,000 after purchasing an additional 37,170 shares during the period. AXA S.A. raised its position in Kenvue by 21.1% in the second quarter. AXA S.A. now owns 48,892 shares of the company's stock worth $1,023,000 after acquiring an additional 8,524 shares during the period. NewEdge Advisors LLC raised its holdings in shares of Kenvue by 219.1% in the 2nd quarter. NewEdge Advisors LLC now owns 97,481 shares of the company's stock worth $2,040,000 after purchasing an additional 66,930 shares during the period. Finally, The Manufacturers Life Insurance Company increased its position in Kenvue by 0.6% in the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company's stock worth $39,217,000 after buying an additional 10,885 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Weiss Ratings upgraded Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research report on Monday, June 15th. Zacks Research cut Kenvue from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 7th. Wall Street Zen downgraded shares of Kenvue from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. UBS Group decreased their price target on Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research note on Tuesday, August 11th. Finally, Barclays boosted their price target on Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a report on Tuesday, July 21st. Three equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. According to data from MarketBeat.com, Kenvue presently has a consensus rating of "Hold" and an average target price of $19.27.

Kenvue Price Performance

Shares of KVUE opened at $17.73 on Friday. The firm's 50-day simple moving average is $19.05 and its two-hundred day simple moving average is $18.24. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $20.13. The stock has a market cap of $34.06 billion, a PE ratio of 20.39, a price-to-earnings-growth ratio of 1.59 and a beta of 0.46. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The company had revenue of $3.96 billion during the quarter, compared to analysts' expectations of $3.97 billion. During the same quarter in the previous year, the company earned $0.29 EPS. The business's quarterly revenue was up 3.0% on a year-over-year basis. Analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 2nd. Shareholders of record on Monday, September 21st will be issued a $0.21 dividend. The ex-dividend date of this dividend is Monday, September 21st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.7%. Kenvue's dividend payout ratio (DPR) is presently 96.55%.

Kenvue Company Profile

Kenvue Inc is a global consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, essential health products, and baby and family care.

The company's brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; Listerine in oral care; and Johnson's and Band-Aid in baby care and essential health.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.